Disclosure Information2026-07-11 04:33:14 (KST)
No Date Title Submitter
23 2025/12/11 [Corrected description]Material Business Matters Related to Investment Decisions Prestige BioPharma Limited
22 2025/11/28 Quarterly Report (2025.09) Prestige BioPharma Limited
21 2025/11/26 Closure of Register of Shareholders or Designation of Record Date Prestige BioPharma Limited
20 2025/11/26 Decision on Calling Shareholders' Meeting Prestige BioPharma Limited
19 2025/11/24 Material Business Matters Related to Investment Decisions Prestige BioPharma Limited
18 2025/11/03 Conclusion of Single Sales Contract or Supply Contract Prestige BioPharma Limited
17 2025/10/31 Report on the Appointment, Dismissal or Early Retirement of Outside Directors Prestige BioPharma Limited
16 2025/10/29 Conclusion of Single Sales Contract or Supply Contract Prestige BioPharma Limited
15 2025/10/13 Report on significant holdings of stocks, etc. (General) Prestige BioPharma Limited
14 2025/09/30 Foreign Corporation, etc. : Report on Appointment or Dismissal or Change of External Auditor Prestige BioPharma Limited
13 2025/09/29 Outcome of Annual Shareholders' Meeting Prestige BioPharma Limited
12 2025/09/29 Report on the Appointment, Dismissal or Early Retirement of Outside Directors Prestige BioPharma Limited
11 2025/09/23 [Corrected description]Annual Report (2025.06) Prestige BioPharma Limited
10 2025/09/23 [Corrected description]Annual Report (2025.06) Prestige BioPharma Limited
9 2025/09/19 Annual Report (2025.06) Prestige BioPharma Limited